BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30378045)

  • 1. Pancreatic Microtumors: A Novel 3D Ex Vivo Testing Platform.
    Goodwin ML; Urs SK; Simeone DM
    Methods Mol Biol; 2019; 1882():73-80. PubMed ID: 30378045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor.
    Nam S; Khawar IA; Park JK; Chang S; Kuh HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-induced Cavitation enhances the efficacy of Chemotherapy in a 3D Model of Pancreatic Ductal Adenocarcinoma with its microenvironment.
    Leenhardt R; Camus M; Mestas JL; Jeljeli M; Abou Ali E; Chouzenoux S; Bordacahar B; Nicco C; Batteux F; Lafon C; Prat F
    Sci Rep; 2019 Dec; 9(1):18916. PubMed ID: 31831785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
    Zhang L; Yao J; Li W; Zhang C
    Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay.
    Wen Z; Liao Q; Hu Y; You L; Zhou L; Zhao Y
    Braz J Med Biol Res; 2013 Jul; 46(7):634-42. PubMed ID: 23903680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
    Takahashi R; Ijichi H; Sano M; Miyabayashi K; Mohri D; Kim J; Kimura G; Nakatsuka T; Fujiwara H; Yamamoto K; Kudo Y; Tanaka Y; Tateishi K; Nakai Y; Morishita Y; Soma K; Takeda N; Moses HL; Isayama H; Koike K
    Sci Rep; 2020 Dec; 10(1):21194. PubMed ID: 33273652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
    Weizman N; Krelin Y; Shabtay-Orbach A; Amit M; Binenbaum Y; Wong RJ; Gil Z
    Oncogene; 2014 Jul; 33(29):3812-9. PubMed ID: 23995783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
    Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
    Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D.
    Laurent J; Frongia C; Cazales M; Mondesert O; Ducommun B; Lobjois V
    BMC Cancer; 2013 Feb; 13():73. PubMed ID: 23394599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Invasive Activity of CAF Spheroids into Three Dimensional (3D) Collagen Matrices.
    Villaronga MÁ; Teijeiro SÁ; Hermida-Prado F; Garzón-Arango M; Sanz-Moreno V; García-Pedrero JM
    Methods Mol Biol; 2018; 1731():145-154. PubMed ID: 29318551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer.
    Wei L; Ye H; Li G; Lu Y; Zhou Q; Zheng S; Lin Q; Liu Y; Li Z; Chen R
    Cell Death Dis; 2018 Oct; 9(11):1065. PubMed ID: 30337520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
    Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
    Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
    Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D
    Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.
    Kuen J; Darowski D; Kluge T; Majety M
    PLoS One; 2017; 12(7):e0182039. PubMed ID: 28750018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.
    Zhang D; Li L; Jiang H; Li Q; Wang-Gillam A; Yu J; Head R; Liu J; Ruzinova MB; Lim KH
    Cancer Res; 2018 Apr; 78(7):1700-1712. PubMed ID: 29363544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment.
    Liu Q; Wu H; Li Y; Zhang R; Kleeff J; Zhang X; Cui M; Liu J; Li T; Gao J; Pan B; Wu W; Wang W; Zhou L; Guo J; Dai M; Zhang T; Liao Q; Lu Z; Zhao Y
    Cancer Immunol Immunother; 2020 Aug; 69(8):1477-1492. PubMed ID: 32285172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
    Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
    Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
    Neumann CCM; von Hörschelmann E; Reutzel-Selke A; Seidel E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):461-472. PubMed ID: 30243879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
    Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
    Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.